The Toronto Stock Exchange reports that Antibe Therapeutics Inc. will be delisted at the close on May 24, 2024. According to the TSX, the company has failed to meet the exchange's continued listing requirements. It will remain suspended from trading.
For more information, see the TSX bulletin dated April 9, 2024.
© 2024 Canjex Publishing Ltd. All rights reserved.